Dr. Kara Dawn Beasley, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4743 Arapahoe Ave, Suite 202, Boulder, CO 80303 Phone: 303-938-5700 Fax: 303-998-0007 |
Dr. Sharad Rajpal, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4743 Arapahoe Ave Ste 202, Boulder, CO 80303 Phone: 303-938-5700 Fax: 303-998-0007 |
Alan Thomas Villavicencio, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4743 Arapahoe Ave, Suite 202, Boulder, CO 80303 Phone: 303-938-5700 Fax: 303-998-0007 |
Dr. Jeffrey J Thramann, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1155 Alpine Ave, Suite 320, Boulder, CO 80304 Phone: 303-998-0004 Fax: 303-998-0007 |
Ewell Lee Nelson, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 4743 Arapahoe Ave, Ste 202, Boulder, CO 80303 Phone: 303-938-5700 Fax: 303-998-0007 |
News Archive
Sanofi and Regeneron Pharmaceuticals, Inc. announced today that several trials within ODYSSEY, the Phase 3 clinical program of SAR236553/REGN727, have initiated patient enrollment.
"Since the Eisenhower administration, the United States generally has done food aid in a certain way: grow and pack it in this country, ship it across the world on U.S.-flagged ships, then deliver it through American charities, which sell a portion of the food to fund their other programs," columnist Michael Gerson writes in a Washington Post opinion piece.
OvaScienceSM, a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended September 30, 2013, as well as recent highlights.
Mayo Clinic researchers found that dopamine agonists used in treating Parkinson's disease result in impulse control disorders in as many as 22 percent of patients.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
› Verified 8 days ago